BMJ Best Practice

参考文献

关键文献

Paparella MM. Pathogenesis and pathophysiology of Meniere's disease. Acta Otolaryngol Suppl. 1991;485:26-35.

Pulec JL. Meniere's disease. Etiology, natural history, and results of treatment. Otolaryngol Clin North Am 1973;6:25-39.

Paparella MM, Djalilian HR. Etiology, pathophysiology of symptoms, and pathogenesis of Meniere's disease. Otolaryngol Clin North Am. 2002;35:529-545.

Paparella MM, Fina M. Endolymphatic sac enhancement: reversal of pathogenesis. Otolaryngol Clin North Am. 2002;35:621-637.

Newman CW, Weinstein BE, Jacobson GP, et al. The Hearing Handicap Inventory for Adults: psychometric adequacy and audiometric correlates. Ear Hear. 1990;11:430-433.

Hanley PJ, Davis PB, Paki B, et al. Treatment of tinnitus with a customized, dynamic acoustic neural stimulus: clinical outcomes in general private practice. Ann Otol Rhinol Laryngol. 2008;117:791-799.

Shea JJ. The role of dexamethasone or streptomycin perfusion in the treatment of Meniere's disease. Otolaryngol Clin North Am. 1997;30:1051-1059.

参考文章

1.  Thirlwall AS, Kundu S. Diuretics for Ménière's disease or syndrome. Cochrane Database Syst Rev. 2006;(3):CD003599.

2.  da Costa SS, de Sousa LC, Piza MR. Meniere's disease: overview, epidemiology, and natural history. Otolaryngol Clin North Am. 2002;35:455-495.

3.  American Academy of Otolaryngology-Head and Neck Foundation. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. Otolaryngol Head Neck Surg. 1995;113:181-185.

4.  Wladislavosky-Waserman P, Facer GW, Mokri B, et al. Meniere's disease: a 30-year epidemiologic and clinical study in Rochester, MN, 1951-1980. Laryngoscope. 1984;94:1098-1102.

5.  Paparella MM. Pathogenesis and pathophysiology of Meniere's disease. Acta Otolaryngol Suppl. 1991;485:26-35.

6.  Huppert D, Strupp M, Brandt T. Long-term course of Menière's disease revisited. Acta Otolaryngol. 2010;130:644-651.

7.  Conlon BJ, Gibson WP. Meniere's disease: the incidence of hydrops in the contralateral asymptomatic ear. Laryngoscope. 1999;109:1800-1802.

8.  Pulec L, House WF. Meniere's disease study: three-year progress report. Int J Equilib Res. 1973;3:156-165.

9.  Pulec JL. Meniere's disease. Etiology, natural history, and results of treatment. Otolaryngol Clin North Am 1973;6:25-39.

10.  Paparella MM, Djalilian HR. Etiology, pathophysiology of symptoms, and pathogenesis of Meniere's disease. Otolaryngol Clin North Am. 2002;35:529-545.

11.  Merchant SN, Adams JC, Nadol JB Jr. Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol. 2005;26:74-81.

12.  Paparella MM, Fina M. Endolymphatic sac enhancement: reversal of pathogenesis. Otolaryngol Clin North Am. 2002;35:621-637.

13.  Selmani Z, Marttila T, Pyykko I. Incidence of virus infection as a cause of Meniere's disease or endolymphatic hydrops assessed by electrocochleography. Eur Arch Otorhinolaryngol. 2005;262:331-334.

14.  de Sousa LC, Piza MR, da Costa SS. Diagnosis of Meniere's disease: routine and extended tests. Otolaryngol Clin North Am. 2002;35:547-564.

15.  Grant IL, Welling DB. The treatment of hearing loss in Meniere's disease. Otolaryngol Clin North Am. 1997;30:1123-1144.

16.  Ballester M, Liard P, Vibert D, et al. Meniere's disease in the elderly. Otol Neurotol. 2002;23:73-78.

17.  Kentala E, Havia M, Pyykko I. Short-lasting drop attacks in Meniere's disease. Otolaryngol Head Neck Surg. 2001;124:526-530.

18.  Lee CS, Paparella MM, Margolis RH, et al. Audiological profiles and Meniere's disease. Ear Nose Throat J. 1995;74:527-532.

19.  Gibson WP, Moffat DA, Ramsden RT. Clinical electrocochleography in the diagnosis and management of Meniere's disorder. Audiology. 1977;16:389-401.

20.  Ferraro JA, Durrant JD. Electrocochleography in the evaluation of patients with Meniere's disease/endolymphatic hydrops. J Am Acad Audiol. 2006;17:45-68.

21.  Conlon BJ, Gibson WP. Electrocochleography in the diagnosis of Meniere's disease. Acta Otolaryngol. 2000;120:480-483.

22.  Al-momani MO, Ferraro JA, Gajewski BJ, et al. Improved sensitivity of electrocochleography in the diagnosis of Meniere's disease. Int J Audiol. 2009;48:811-819.

23.  Ferraro JA. Electrocochleography: a review of recording approaches, clinical applications, and new findings in adults and children. J Am Acad Audiol. 2010;21:145-152.

24.  Ferraro J. Electrocochleography. In: Ross JR, Valente M, Hosford-Dunn H, eds. Audiologic diagnosis. 2nd ed. New York, NY: Thieme; 2000:425-450.

25.  Gürkov R, Flatz W, Louza J, et al. In vivo visualization of endolymphatic hydrops in patients with Meniere's disease: correlation with audiovestibular function. Eur Arch Otorhinolaryngol. 2011;268:1743-1748.

26.  Sano R, Teranishi M, Yamazaki M, et al. Contrast enhancement of the inner ear in magnetic resonance images taken at 10 minutes or 4 hours after intravenous gadolinium injection. Acta Otolaryngol. 2012;132:241-246.

27.  Agrup C, Luxon LM. Immune-mediated inner-ear disorders in neuro-otology. Curr Opin Neurol. 2006;19:26-32.

28.  Jerger J, Jerger S. Diagnostic significance of PB word functions. Arch Otolaryngol. 1971;93:573-580.

29.  Fetterman BL. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops. Laryngoscope. 2001;111:946-954.

30.  Young YH, Huang TW, Cheng PW. Assessing the stage of Meniere's disease using vestibular evoked myogenic potentials. Arch Otolaryngol Head Neck Surg. 2003;129:815-818.

31.  Kentala E, Pyykkö I. Vestibular schwannoma mimicking Ménière's disease. Acta Otolaryngol Suppl. 2000;543:17-19.

32.  Shepard NT. Differentiation of Meniere's disease and migraine-associated dizziness: a review. J Am Acad Audiol. 2006;17:69-80.

33.  Roland PS, Marple BF, Meyerhoff WL, eds. Hearing loss. New York, NY: Thieme Medical Publishers, Inc.; 1997.

34.  Karlberg M, Hall K, Quickert N, et al. What inner ear diseases cause benign paroxysmal positional vertigo? Acta Otolaryngol. 2000;120:380-385.

35.  Bhattacharyya N, Gubbels SP, Schwartz SR, et al. Clinical practice guideline: benign paroxysmal positional vertigo (update). Otolaryngol Head Neck Surg. 2017;156:S1-S47.

36.  Baloh RW. The dizzy patient. Postgrad Med. 1999;105:161-164, 167-172.

37.  Kinney SE, Sandridge SA, Newman CW. Long-term effects of Meniere's disease on hearing and quality of life. Am J Otol. 1997;18:67-73.

38.  Hamill TA. Evaluating treatments for Meniere's disease: controversies surrounding placebo control. J Am Acad Audiol. 2006;17:27-37.

39.  Gacek RR, Gacek MR. Menière's disease as a manifestation of vestibular ganglionitis. Am J Otolaryngol. 2001;22:241-250.

40.  Rickenstein MJ, Harrison RV. Cochlear pathophysiology in Meniere’s disease: a critical appraisal. In: Harris JP, ed. Ménière’s disease. The Hague, Netherlands: Kugler Publications; 1999:195-202.

41.  Boles R, Rice DH, Hybels R, et al. Conservative management of Meniere's disease: Furstenberg regimen revisited. Ann Otol Rhinol Laryngol. 1975;84:513-517.

42.  Brown JS. A ten year statistical follow-up of 245 consecutive cases of endolymphatic shunt and decompression with 328 consecutive cases of labyrinthectomy. Laryngoscope. 1983;93:1419-1424.

43.  Glasscock ME, Gulya AJ, Pensak ML, et al. Medical and surgical management of Meniere's disease. Am J Otol. 1984;5:536-542.

44.  Santos PM, Hall RA, Snyder JM, et al. Diuretic and diet effect on Meniere's disease evaluated by the 1985 Committee on Hearing and Equilibrium guidelines. Otolaryngol Head Neck Surg. 1993;109:680-689.

45.  Colletti V. Medical treatment in Meniere's disease: avoiding vestibular neurectomy and facilitating postoperative compensation. Acta Otolaryngol Suppl. 2000;544:27-33.

46.  Nishiyama S, Okada T, Kobayashi T, et al. Na-K-ATPase activity in the guinea pig stria vascularis in experimentally-induced endolymphatic hydrops. Histol Histopathol. 1994;9:205-209.

47.  Wright T. Meniere's disease. BMJ Clin Evid. November 2015. http://www.clinicalevidence.bmj.com/ (last accessed 18 March 2017).

48.  James AL, Burton MJ. Betahistine for Menière's disease or syndrome. Cochrane Database Syst Rev. 2001;(1):CD001873.

49.  Silverstein H, Isaacson JE, Olds MJ, et al. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial. Am J Otol. 1998;19:196-201.

50.  Newman CW, Weinstein BE, Jacobson GP, et al. The Hearing Handicap Inventory for Adults: psychometric adequacy and audiometric correlates. Ear Hear. 1990;11:430-433.

51.  Newman CW, Jacobson GP, Spitzer JB. Development of the Tinnitus Handicap Inventory. Arch Otolaryngol Head Neck Surg. 1996;122:143-148.

52.  Newman CW, Sandridge SA, Jacobson GP. Psychometric adequacy of the Tinnitus Handicap Inventory (THI) for evaluating treatment outcome. J Am Acad Audiol. 1998;9:153-160.

53.  Jastreboff PJ, Hazell JW. A neurophysiological approach to tinnitus: clinical implications. Br J Audiol. 1993;27:7-17.

54.  Jastreboff PJ, Hazell JWP. Treatment of tinnitus based on a neurophysiological model. In: Vernon J, ed. Tinnitus: treatment and relief. Boston, MA: Allyn & Bacon; 1998:201-216.

55.  Davis PB, Paki B, Hanley PJ. Neuromonics Tinnitus Treatment: third clinical trial. Ear Hear. 2007;28:242-259.

56.  Hanley PJ, Davis PB, Paki B, et al. Treatment of tinnitus with a customized, dynamic acoustic neural stimulus: clinical outcomes in general private practice. Ann Otol Rhinol Laryngol. 2008;117:791-799.

57.  Davis PB, Wilde RA, Steed LG, et al. Treatment of tinnitus with a customized acoustic neural stimulus: a controlled clinical study. Ear Nose Throat J. 2008;87:330-339.

58.  Johnson RM, Brummett R, Schleuning A. Use of alprazolam for relief of tinnitus. A double-blind study. Arch Otolaryngol Head Neck Surg. 1993;119:842-845.

59.  Valente M, Mispagel K, Valente LM, et al. Problems and solutions for fitting amplification to patients with Meniere's disease. J Am Acad Audiol. 2006;17:6-15.

60.  Shea JJ, Ge X. Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Meniere's disease. Otolaryngol Clin North Am. 1996;29:353-358.

61.  Shea JJ. The role of dexamethasone or streptomycin perfusion in the treatment of Meniere's disease. Otolaryngol Clin North Am. 1997;30:1051-1059.

62.  Barrs DM, Keyser JS, Stallworth C, et al. Intratympanic steroid injections for intractable Meniere's disease. Laryngoscope. 2001;111:2100-2104.

63.  Chia SH, Gamst AC, Anderson JP, et al. Intratympanic gentamicin therapy for Meniere's disease: a meta-analysis. Otol Neurotol. 2004;25:544-552.

64.  Cohen-Kerem R, Kisilevsky V, Einarson TR, et al. Intratympanic gentamicin for Menière's disease: a meta-analysis. Laryngoscope. 2004;114:2085-2091.

65.  Postema RJ, Kingma CM, Wit HP, et al. Intratympanic gentamicin therapy for control of vertigo in unilateral Menire's disease: a prospective, double-blind, randomized, placebo-controlled trial. Acta Otolaryngol. 2008;128:876-880.

66.  Stokroos R, Olvink MK, Hendrice N, et al. Functional outcome of treatment of Meniere's disease with the Meniett pressure generator. Acta Otolaryngol. 2006;126:254-258.

67.  Gates GA, Verrall A, Green JD, et al. Meniett clinical trial: long-term follow-up. Arch Otolaryngol Head Neck Surg. 2006;132:1311-1316.

68.  Thomsen J, Sass K, Odkvist L, et al. Local overpressure treatment reduces vestibular symptoms in patients with Meniere's disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study. Otol Neurotol. 2005;26:68-73.

69.  van Sonsbeek S, Pullens B, van Benthem PP. Positive pressure therapy for Ménière's disease or syndrome. Cochrane Database Syst Rev. 2015;(3):CD008419.

70.  McDonnell MN, Hillier SL. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev. 2015;(1):CD005397.

71.  Hansson EE. Vestibular rehabilitation: for whom and how? A systematic review. Adv Physiother. 2007;9:106-116.

72.  Gottshall KR, Hoffer ME, Moore RJ, et al. The role of vestibular rehabilitation in the treatment of Meniere's disease. Otolaryngol Head Neck Surg. 2005;133:326-328.

73.  Bretlau P, Thomsen J, Tos M, et al. Placebo effect in surgery for Meniere's disease: nine-year follow-up. Am J Otol. 1989;10:259-261.

74.  Pillsbury HC, Arenberg IK, Ferraro J, et al. Endolymphatic sac surgery. The Danish sham surgery study: an alternative analysis. Otolaryngol Clin North Am. 1983;16:123-127.

75.  Thomsen J, Bretlau P, Tos M, et al. Meniere's disease: endolymphatic sac decompression compared with sham (placebo) decompression. Ann N Y Acad Sci. 1981;374:820-830.

76.  Thomsen J, Bonding P, Becker B, et al. The non-specific effect of endolymphatic sac surgery in treatment of Meniere's disease: a prospective, randomized controlled study comparing "classic" endolymphatic sac surgery with the insertion of a ventilating tube in the tympanic membrane. Acta Otolaryngol. 1998;118:769-773.

77.  Pullens B, Verschuur HP, van Benthem PP. Surgery for Ménière's disease. Cochrane Database Syst Rev. 2013;(2):CD005395.

78.  Paparella MM, Sajjadi H. Endolymphatic sac enhancement. Principles of diagnosis and treatment. Am J Otol. 1987;8:294-300.

79.  Silverstein H, Jackson LE. Vestibular nerve section. Otolaryngol Clin North Am. 2002;35:655-673.

80.  Møller MN, Cayé-Tomasen P, Thomsen JH. Vestibular nerve section in the treatment of morbus Ménière [in Danish]. Ugeskr Laeger. 2009;171:1000-1003.

81.  Berryhill WE, Graham MD. Chemical and physical labyrinthectomy for Meniere's disease. Otolaryngol Clin North Am. 2002;35:675-682.

82.  Graham MD, Colton JJ. Transmastoid labyrinthectomy indications. Technique and early postoperative results. Laryngoscope. 1980;90:1253-1262.

83.  Lustig LR, Yeagle J, Niparko JK, et al. Cochlear implantation in patients with bilateral Ménière's syndrome. Otol Neurotol. 2003;24:397-403.

84.  Pothula VB, Chew F, Lesser TH, et al. Falls and vestibular impairment. Clin Otolaryngol Allied Sci. 2004;29:179-182.

使用此内容应接受我们的免责声明